M. Schreijenberg

Paracetamol for low back pain: the state of the research field

B. Koes, M. Schreijenberg, A. Tkachev, 2020, Expert review of clinical pharmacology.

Discontinuation of the PACE Plus trial: problems in patient recruitment in general practice

D. Rizopoulos, M. Koopmanschap, C. Maher, 2018, BMC Musculoskeletal Disorders.

Inferential reproduction analysis demonstrated that 'Paracetamol for Acute Low Back Pain' trial conclusions were reproducible.

B. Koes, C. Maher, A. Chiarotto, 2020, Journal of clinical epidemiology.

Guideline recommendations on the pharmacological management of non-specific low back pain in primary care – is there a need to change?

B. Koes, C. Lin, M. Schreijenberg, 2019, Expert review of clinical pharmacology.

Efficacy of paracetamol, diclofenac and advice for acute low back pain in general practice: design of a randomized controlled trial (PACE Plus)

D. Rizopoulos, M. Koopmanschap, C. Maher, 2017, BMC Musculoskeletal Disorders.

Effectiveness of placebo interventions for patients with non-specific low back pain: a systematic review.

B. Koes, A. Chiarotto, M. Schreijenberg, 2021, Pain.

Paracetamol is ineffective for acute low back pain even for patients who comply with treatment: complier average causal effect analysis of a randomized controlled trial.

B. Koes, C. Maher, S. Kamper, 2019, Pain.